Effect of compensated renal dysfunction on approved heart failure markers -: Direct comparison of brain natriuretic peptide (BNP) and N-terminal Pro-BNP

被引:144
作者
Luchner, A
Hengstenberg, C
Löwel, H
Riegger, GAJ
Schunkert, H
Holmer, S
机构
[1] Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Epidemiol, Neuherberg, Germany
[3] Univ Schleswig Holstein, Lubeck, Germany
关键词
myocardial infarction; ventricular function; hypertrophy; kidney; natriuretic peptides;
D O I
10.1161/01.HYP.0000170140.36633.8f
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Brain natriuretic peptide ( BNP) and N-terminal pro-BNP ( NT-proBNP) are markers of heart failure. Although renal dysfunction may increase plasma concentrations, the magnitude of this effect has not been assessed in a head-to-head comparison between the clinically approved tests. We assessed the effect of compensated renal dysfunction on BNP ( Triage BNP; Biosite) and NT-proBNP ( elecsys proBNP; Roche) in 469 randomly selected stable outpatients after myocardial infarction ( MI; Monitoring Trends and Determinants in Cardiovascular Diseases [ MONICA] register Augsburg) who were characterized with respect to renal function ( glomerular filtration rate [ GFR]; Cockroft method) and left ventricular ( LV) ejection fraction ( EF) and mass ( 2D echocardiography). BNP and NT-proBNP were elevated in MI patients with LV dysfunction ( LVD; EF <35%) compared with MI patients with preserved EF ( >45%; BNP 139 +/- 27 pg/mL versus 75 +/- 6; NT-proBNP 816 +/- 237 pg/mL versus 243 +/- 20; both P < 0.03). Among all MI patients, the prevalence of renal dysfunction ( GFR <85 mL/min) was 24%. BNP and NT-proBNP were significantly elevated in MI patients with renal dysfunction ( BNP 132 +/- 17 pg/mL versus 68 +/- 4 without renal dysfunction; NT-proBNP 535 +/- 80 pg/mL versus 232 +/- 19; both P < 0.05), and both markers were correlated with GFR in univariate and multivariate analyses ( all P < 0.01). When binary cut-off values were stratified according to the absence or presence of renal dysfunction ( BNP 75 pg/mL and 125 pg/mL, respectively; NT-proBNP 100 pg/mL and 350pg/mL, respectively), the predictive power of both markers for the detection of LVD increased substantially. BNP and NT-proBNP are almost similarly influenced by mild-to-moderate renal dysfunction. Renal dysfunction is a potential cause of elevated marker concentrations in the absence of LVD, and cut-off concentrations should be stratified according to renal function.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 24 条
  • [1] Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
  • [2] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
    Berger, R
    Huelsman, M
    Strecker, K
    Bojic, A
    Moser, P
    Stanek, B
    Pacher, R
    [J]. CIRCULATION, 2002, 105 (20) : 2392 - 2397
  • [3] Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling
    Cataliotti, A
    Malatino, LS
    Jougasaki, M
    Zoccali, C
    Castellino, P
    Giacone, G
    Bellanuova, I
    Tripepi, R
    Seminara, G
    Parlongo, S
    Stancanelli, B
    Bonanno, G
    Fatuzzo, P
    Rapisarda, F
    Belluardo, P
    Signorelli, SS
    Heublein, DM
    Lainchbury, JG
    Leskinen, HK
    Bailey, KR
    Redfield, MM
    Burnett, JC
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1111 - 1119
  • [4] Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis
    Clerico, A
    Caprioli, R
    Del Ry, S
    Giannessi, D
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (01) : 24 - 30
  • [5] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [6] METHODS FOR DETECTION OF LEFT-VENTRICULAR HYPERTROPHY - APPLICATION TO HYPERTENSIVE HEART-DISEASE
    DEVEREUX, RB
    KOREN, MJ
    DESIMONE, G
    OKIN, PM
    KLIGFIELD, P
    [J]. EUROPEAN HEART JOURNAL, 1993, 14 : 8 - 15
  • [7] RAPID VENTRICULAR INDUCTION OF BRAIN NATRIURETIC PEPTIDE GENE-EXPRESSION IN EXPERIMENTAL ACUTE MYOCARDIAL-INFARCTION
    HAMA, N
    ITOH, H
    SHIRAKAMI, G
    NAKAGAWA, O
    SUGA, S
    OGAWA, Y
    MASUDA, I
    NAKANISHI, K
    YOSHIMASA, T
    HASHIMOTO, Y
    YAMAGUCHI, M
    HORI, R
    YASUE, H
    NAKAO, K
    [J]. CIRCULATION, 1995, 92 (06) : 1558 - 1564
  • [8] Renal function, neurohormonal activation, and survival in patients with chronic heart failure
    Hillege, HL
    Girbes, ARJ
    de Kam, PJ
    Boomsma, F
    de Zeeuw, D
    Charlesworth, A
    Hampton, JR
    van Veldhuisen, DJ
    [J]. CIRCULATION, 2000, 102 (02) : 203 - +
  • [9] N-terminal pro-brain natriuretic peptide after myocardial infarction -: A marker of cardio-renal function
    Luchner, A
    Hengstenberg, C
    Löwel, H
    Trawinski, J
    Baumann, M
    Riegger, GAJ
    Schunkert, H
    Holmer, S
    [J]. HYPERTENSION, 2002, 39 (01) : 99 - 104
  • [10] Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population
    Luchner, A
    Burnett, JC
    Jougasaki, M
    Hense, HW
    Heid, IM
    Muders, F
    Riegger, GAJ
    Schunkert, H
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 (08) : 1121 - 1128